Skip to content

Use test of moisturizer for patients with atopic dermatitis and patients receiving EGFR inhibitor-nonrandomized/nonblinded-

Use test of moisturizer for patients with atopic dermatitis and patients receiving EGFR inhibitor-nonrandomized/nonblinded- - Use test of moisturizer for patients with atopic dermatitis and patients receiving EGFR inhibitor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025686
Enrollment
20
Registered
2017-01-15
Start date
2017-02-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis, psoriasis, Patient receiving EGFR inhibitor

Interventions

Sponsors

Hokkaido University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ?Patients with skin disorders such as atopic dermatitis, psoriasis or the like, or patients with dry symptoms of the skin by EGFR inhibitor administration ?Those who are judged to be expected to improve dry skin symptoms due to the use of this research item ?The treatment of the original disease is not restricted ?There is no problem in terms of age and gender (including children) ?After receiving sufficient explanation for participation in this research, after sufficient understanding, the patient himself (a substitute in the case of a minor, but the principal and the substitute person over the age of 16 is free) by the free will Patient who got written consent

Exclusion criteria

Exclusion criteria: ?Person who experienced skin symptoms such as contact dermatitis due to the ingredients of this research item and similar ingredients ?Persons who have skin lesions etc. that are inappropriate for the application of this research item at the application site ?Persons who can not be examined after 8 weeks (in principle) ?pregnancy and lactating ?In addition, patients who the research staff judged inappropriate as subjects

Design outcomes

Primary

MeasureTime frame
Improvement of skin dryness (skin findings) Drying scores before and after the test at each observation site have changed by 1 or more

Secondary

MeasureTime frame
Skin physiological verification (changes in skin measurement value and cytokine in epidermal horny layer) Changes in stratum corneum water content, epidermal water transpiration amount, IL-1a, TARC, TSLP Improvement of QOL and feeling of use of this research product by questionnaire Changes in the subscales (functions, symptoms, emotions, comprehensive) of Skindex - 16 which is a skin disease specific scale and feeling of use feeling (feeling of moisture, stickiness, etc.) of the questionnaire

Countries

Japan

Contacts

Public ContactHiroaki Iwata

Hokkaido University Hospital Dermatology

hiriwata0927@yahoo.co.jp011-716-1161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026